Skip to main content

Want a detailed portfolio tracker?

OverviewPerformanceMetricsFinancialsETFsIndustryCorrelations
Market CapEPSP/EP/SP/BSharesProfit MarginOperating MarginDebt to EquityRevenueEarningsEBITDAFree Cash FlowTotal DebtTotal AssetsROAROE

Chimerix (CMRX) Operating Margin (2013 - 2024)

Chimerix (CMRX) operating margin from Jun 30, 2013 to Dec 31, 2024. The current Chimerix (CMRX) operating margin is -40916.67%. You can export chart.

Annual Operating Margin

Quarterly Operating Margin

Annual Operating Margin change of Chimerix (CMRX)

YearOperating MarginChange
2024-45985.71%
+58.13%
2023-29081.25%
+16186.27%
2022-178.56%
-97.96%
2021-8757.58%
+956.34%
2020-829.05%
-10.50%
2019-926.36%
-6.59%
2018-991.69%
-38.24%
2017-1605.79%
+17.42%
2016-1367.54%
+24.44%
2015-1098.98%
-24.58%
2014-1457.18%
+122.50%
2013-654.92%
N/A

Comparison Chimerix (CMRX) operating margin with competitors

Chimerix (CMRX) operating margin is -40916.67%.

TickerNameOperating MarginUpside
VIRVir Biotechnology Inc459241.00%-1222.38%
APLMApollomics Inc - Class A431.90%-101.06%
ABUSArbutus Biopharma Corp94.30%-100.23%
SAVACassava Sciences Inc.93.36%-100.23%
RPRXRoyalty Pharma plc - Class A89.29%-100.22%
GLPGGalapagos NV84.24%-100.21%
NEUPNeuphoria Therapeutics Inc79.85%-100.20%
BDTXBlack Diamond Therapeutics Inc77.90%-100.19%
CTNMContineum Therapeutics Inc - Class A77.87%-100.19%
CVACCureVac N.V.74.59%-100.18%
IPSCCentury Therapeutics Inc67.95%-100.17%
FULCFulcrum Therapeutics Inc65.62%-100.16%
AVIRAtea Pharmaceuticals Inc63.06%-100.15%
PLXProtalix BioTherapeutics Inc62.65%-100.15%
PRTAProthena Corporation plc58.80%-100.14%
AUPHAurinia Pharmaceuticals Inc53.31%-100.13%
ADMAAdma Biologics Inc50.90%-100.12%
RPTXRepare Therapeutics Inc50.85%-100.12%
CRMDCorMedix Inc49.96%-100.12%
HCWBHCW Biologics Inc49.78%-100.12%
CPRXCatalyst Pharmaceuticals Inc49.02%-100.12%
SRPTSarepta Therapeutics Inc49.00%-100.12%
HALOHalozyme Therapeutics Inc48.98%-100.12%
KRYSKrystal Biotech Inc46.14%-100.11%
AGENAgenus Inc44.62%-100.11%
CGENCompugen Ltd43.05%-100.11%
SVASinovac Biotech Ltd42.30%-100.10%
EXELExelixis Inc41.15%-100.10%
QTTBQ32 Bio Inc39.80%-100.10%
INVAInnoviva Inc38.94%-100.10%
VRTXVertex Pharmaceuticals Inc38.10%-100.09%
NXTCNextcure Inc36.70%-100.09%
LGNDLigand Pharmaceuticals Inc - Class B33.58%-100.08%
SLNOSoleno Therapeutics Inc33.06%-100.08%
JAZZJazz Pharmaceuticals plc31.49%-100.08%
ARGXArgen X SE30.35%-100.07%
CAICaris Life Sciences Inc - Class A30.19%-100.07%
TNGXTango Therapeutics Inc26.15%-100.06%
GMABGenmab25.11%-100.06%
ZVRAZevra Therapeutics Inc24.40%-100.06%
TECHBio-Techne Corp24.24%-100.06%
INCYIncyte Corp23.66%-100.06%
RIGLRigel Pharmaceuticals20.21%-100.05%
ICCCImmucell Corp19.01%-100.05%
REGNRegeneron Pharmaceuticals Inc17.83%-100.04%
NERVMinerva Neurosciences Inc17.73%-100.04%
HRMYHarmony Biosciences Holdings Inc17.31%-100.04%
TGTXTG Therapeutics Inc16.98%-100.04%
BMRNBiomarin Pharmaceutical Inc16.92%-100.04%
ONCBeiGene Ltd16.51%-100.04%
PTCTPTC Therapeutics Inc16.50%-100.04%
ENVBEnveric Biosciences Inc13.38%-100.03%
VXRTVaxart Inc13.19%-100.03%
VRNAVerona Pharma Plc12.90%-100.03%
ALNYAlnylam Pharmaceuticals Inc12.01%-100.03%
ASNDAscendis Pharma A/S10.06%-100.02%
APLSApellis Pharmaceuticals Inc9.86%-100.02%
FOLDAmicus Therapeutics Inc8.61%-100.02%
CGEMCullinan Oncology Inc7.24%-100.02%
IMCRImmunocore Holdings plc6.82%-100.02%
NAGENiagen Bioscience Inc5.01%-100.01%
NUVBNuvation Bio Inc - Class A4.66%-100.01%
BMEABiomea Fusion Inc2.46%-100.01%
TLXTelix Pharmaceuticals Ltd1.58%-100.00%
HOTHHoth Therapeutics Inc0.17%-100.00%
BBLGBone Biologics Corp0.04%-100.00%